Literature DB >> 3139557

The susceptibility to insulin-dependent diabetes mellitus is associated with C4 allotypes independently of the association with HLA-DQ alleles in HLA-DR3,4 heterozygotes.

M Thomsen1, J Mølvig, A Zerbib, C de Preval, M Abbal, J M Dugoujon, E Ohayon, A Svejgaard, A Cambon-Thomsen, J Nerup.   

Abstract

In the genetically homogeneous Danish population, 27 HLA-DR3,4 heterozygous patients with insulin-dependent diabetes mellitus (IDDM) and 19 DR3,4 heterozygous controls without family history of IDDM were investigated for HLA-region markers and Gm and Km immunoglobulin allotypes. The aim was to define susceptibility factors for IDDM development other than HLA-DR using a number of techniques: lymphocytotoxicity (HLA-DR and DQ antigens), cellular methods (Dw and DP typing), restriction fragment length polymorphism (DQ alleles), electrophoresis and immunofixation (BF and C4 allotypes), and passive hemagglutination inhibition (Gm and Km immunoglobulin allotypes). The complement allotype C4A3 and the HLA-DQw8 (DQw3.2) antigen were found in all of the patients, whereas this was the case for only 8 of the 19 controls (P = 6 x 10(-6)): five lacked C4A3, five others lacked DQw8, and one of the controls lacked both of these factors. Fourteen of the patients had the complement allotype C4B3 versus three of the controls (P = 0.01). Previously reported family studies suggest that these alleles are part of the following haplotype: B15, BFS, C4A3, C4B3, DR4, Dw4, DQw8, and these factors were found together in ten of the patients versus one of the controls (P = 0.01). The markers usually associated with DR3 did not show significant differences between IDDM patients and controls, and the non-HLA markers studied showed no significant deviation from what was expected. In addition to the susceptibility factor DQw8, the study suggests the existence of susceptibility genes for IDDM near the complement C4 genes on DR4-carrying haplotypes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139557     DOI: 10.1007/bf00364230

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  45 in total

1.  Data reduction in HLA-D typing with the primed lymphocyte typing (PLT) technique. the normalized median response (NMR).

Authors:  N Morling; P Platz; L P Ryder; A Svejgaard; M Thomsen
Journal:  Tissue Antigens       Date:  1980-02

2.  Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.

Authors:  T Spies; C C Morton; S A Nedospasov; W Fiers; D Pious; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  A new HLA-D specificity associated with DR blank: D-BON.

Authors:  A Cambon-Thomsen; M Thomsen; M Abbal; E Sommer; M Calot; E Ohayon
Journal:  Tissue Antigens       Date:  1986-05

4.  Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J Nerup; C A Dinarello; M Svenson; J H Nielsen
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

5.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

Authors:  H Acha-Orbea; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families.

Authors:  L Contu; I Deschamps; H Lestradet; J Hors; M Schmid; M Busson; A Benajam; A Marcelli-Barge; J Dausset
Journal:  Tissue Antigens       Date:  1982-08

7.  Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.

Authors:  T Mandrup-Poulsen; K Bendtzen; C A Dinarello; J Nerup
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

Review 8.  Heterogeneity in diabetes mellitus--update, 1978. Evidence for further genetic heterogeneity within juvenile-onset insulin-dependent diabetes mellitus.

Authors:  J I Rotter; D L Rimoin
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461

9.  HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population.

Authors:  A Svejgaard; B K Jakobsen; P Platz; L P Ryder; J Nerup; M Christy; K Borch-Johnsen; H H Parving; T Deckert; L Mølsted-Pedersen
Journal:  Tissue Antigens       Date:  1986-10

10.  Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation.

Authors:  D J Charron; V Lotteau; P Turmel
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

View more
  12 in total

1.  Genetic structure of the novel low-frequency haplotype HLA-B49, SC01, DR4 and its contribution to insulin-dependent diabetes susceptibility.

Authors:  O G Segurado; P Iglesias-Casarrubios; P Morales; J Martínez-Laso; J Partanen; R D Campbell; A Arnaiz-Villena
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  Genetic analysis of susceptibility to type 1 diabetes.

Authors:  J A Todd
Journal:  Springer Semin Immunopathol       Date:  1992

3.  TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus.

Authors:  K Badenhoop; G Schwarz; J Trowsdale; V Lewis; K H Usadel; E A Gale; G F Bottazzo
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

4.  The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene.

Authors:  B A Lie; J A Todd; F Pociot; J Nerup; H E Akselsen; G Joner; K Dahl-Jørgensen; K S Rønningen; E Thorsby; D E Undlien
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

5.  Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis.

Authors:  B Mulcahy; F Waldron-Lynch; M F McDermott; C Adams; C I Amos; D K Zhu; R H Ward; D O Clegg; F Shanahan; M G Molloy; F O'Gara
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

6.  Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM.

Authors:  M A Degli-Esposti; L J Abraham; V McCann; T Spies; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

7.  Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1 beta.

Authors:  S Helqvist; B S Polla; J Johannesen; J Nerup
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

8.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes.

Authors:  C V Jongeneel; L Briant; I A Udalova; A Sevin; S A Nedospasov; A Cambon-Thomsen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

9.  HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.

Authors:  P J Tienari; E Tuomilehto-Wolf; J Tuomilehto; L Peltonen
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

10.  The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese.

Authors:  J A Todd; Y Fukui; T Kitagawa; T Sasazuki
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.